Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SKINSHIFT is a consumer health and personalized skincare company focused on DNA-based skin analysis and customized skincare regimens. The company markets a genetic analysis-based program designed to identify skin-related genetic traits and recommend individualized skin care products and supplements. Its business appears centered on commercial skincare products and wellness offerings rather than prescription therapeutics or a traditional drug-development pipeline. The brand was developed by Ruthie Harper, MD, and is associated with Austin, Texas. Based on available public information, SKINSHIFT is an active private company operating in the genomics-enabled skincare and beauty/wellness segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SKINSHIFT.